ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,599.50
4.50 (0.28%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.50 0.28% 1,599.50 1,604.00 1,605.00 1,612.50 1,591.00 1,600.50 5,248,767 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.40 66.06B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,595p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £66.06 billion. Gsk has a price to earnings ratio (PE ratio) of 13.40.

Gsk Share Discussion Threads

Showing 33026 to 33049 of 33300 messages
Chat Pages: 1332  1331  1330  1329  1328  1327  1326  1325  1324  1323  1322  1321  Older
DateSubjectAuthorDiscuss
15/3/2024
13:59
Today is particularly disappointing at present ..... ;0(
tradermichael
15/3/2024
13:58
Fall due to the rkt litigation decision in the US ?
panache1
15/3/2024
13:37
I know I shouldn't be, but slightly frustrated that it seems rangebound at the moment. News flow has been very good the past few months and hopefully that will continue!
rikky72
13/3/2024
20:48
More than!
patientcapital
13/3/2024
15:56
It will be interesting if GSK can do AZN over the next several years, shareprice wise... 🤞
igoe104
13/3/2024
15:42
Looking good here 2024 a good year for gsk
supermarky
13/3/2024
13:18
M. Fool asserts: Even before the latest announcements, GSK looked undervalued compared to its peers.

On the key price-to-earnings (P/E) ratio measurement, it currently trades at just 13.8 against a peer group average of 25.3.

A discounted cash flow analysis shows GSK shares to be around 58% undervalued at their current price of £16.81. Therefore, a fair value would be around £40.00.

tradermichael
13/3/2024
09:43
Deutsche Bank reissued their buy rating on shares of GSK (LON:GSK) in a research note published on Tuesday. Deutsche Bank currently has a GBX 1,950 target price on the stock.
tradermichael
11/3/2024
14:28
Still very cheap ..... ;0)
tradermichael
08/3/2024
17:03
Sterling's relative strength not helping Dollar earnings. Some profit taking perhaps. Still cheap though.
patientcapital
08/3/2024
13:01
You can't have pancakes every day
abdullla
08/3/2024
12:46
Why the fall today ?
alibizzle
07/3/2024
22:18
Including the Haleon shares we are not far behind.
pcok
07/3/2024
15:42
She deserves her 50% increase this year .... ;0)
tradermichael
07/3/2024
11:43
Great RNS. Good share price reaction so far. Any of the usual suspects want a pop at our incompetent CEO today? The silence is deafening.
pcok
07/3/2024
10:22
Novo Nordisk also having a big up day if you're following the granolas
dplewis1
07/3/2024
10:19
Hopefully 1800 coming with a bit of luck
supermarky
07/3/2024
09:26
back above where we should be..
lippy4
07/3/2024
09:09
Lovely to see these break above £17 now, next step £18 hopefully in the next couple of months...
igoe104
07/3/2024
07:35
GSK announces positive results from DREAMM-8 phase III trial for Blenrep versus standard of care combination in relapsed/refractory multiple myeloma
panache1
07/3/2024
07:12
Good RNS this morning positive news should be positive for the share price
evianone
06/3/2024
12:08
Only news I can see is the WHO saying resistance to GSK's drug dolutegravir has exceeded levels observed during trials
dplewis1
06/3/2024
11:13
Why the drop today
mj19
04/3/2024
14:19
On Monday, Guggenheim Securities adjusted its stance on shares of GlaxoSmithKline (NYSE:GSK), upgrading the stock from Neutral to Buy. The firm's decision follows recent updates on the company's revenue and a growing confidence in the potential for margin benefits.

The firm has set a price target for GlaxoSmithKline at £20.31 per share, which represents a 22% potential increase from the last closing price.

tradermichael
Chat Pages: 1332  1331  1330  1329  1328  1327  1326  1325  1324  1323  1322  1321  Older

Your Recent History

Delayed Upgrade Clock